日本語View as Markdown

μ-Chlorido-bis-{[1-benzyl-3-(2,4,6-tri-methyl-phen-yl)imidazol-2-yl-idene-κ]silver(I)} chloride 1,2-di-chloro-ethane hemisolvate.

ベンジル基およびメシチル基を有するN複素環カルベン銀(I)錯体の結晶構造と抗菌特性

other not specified not assessed

Abstract

A dinuclear silver(I) complex bridged by a chlorido ligand was prepared from an imidazolium chloride precursor bearing benzyl and 2,4,6-trimethylphenyl (mesityl) N-substituents, using sodium bis(trimethylsilyl)amide and silver chloride as reagents. Structural characterization by NMR spectroscopy and single-crystal X-ray diffraction at 110 K revealed monoclinic symmetry (space group 2/m). The crystal packing features multiple weak intermolecular hydrogen-bonding contacts involving the chloride counter-anion. The compound is noted for its potential antibacterial properties.

Bibliographic

Authors
Malek K, Arumugam K
Journal
IUCrdata
Year
2024
PMID
39371668
DOI
10.1107/S2414314624008617
PMC
PMC11451033

Delivery context

The delivery route is not clearly identifiable from this paper. For hydrogen intake, inhalation is the most efficient route; inhalation, however, carries explosion risk (empirical LFL of 10%; high-concentration devices are not recommended).

Safety notes

The delivery route is not clearly identifiable from this paper. For hydrogen intake, inhalation is the most efficient route; inhalation, however, carries explosion risk (empirical LFL of 10%; high-concentration devices are not recommended).

See also:

Cite as: H2 Papers — PMID 39371668. https://h2-papers.org/en/papers/39371668
Source: PubMed PMID 39371668